Increased Identification of Vaccines for Vaccine Safety Surveillance Through Linkage With the Minnesota Immunization Information Connection as of December 31, 2023.

IF 3 4区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Public Health Reports Pub Date : 2024-09-28 DOI:10.1177/00333549241280002

Jingyi Zhu, Gabriela Vazquez-Benitez, Malini B DeSilva, Leslie Kuckler, Nicole Trower, Miriam Halstead Muscoplat, Aaron Bieringer, Holly C Groom, Elyse O Kharbanda

{"title":"Increased Identification of Vaccines for Vaccine Safety Surveillance Through Linkage With the Minnesota Immunization Information Connection as of December 31, 2023.","authors":"Jingyi Zhu, Gabriela Vazquez-Benitez, Malini B DeSilva, Leslie Kuckler, Nicole Trower, Miriam Halstead Muscoplat, Aaron Bieringer, Holly C Groom, Elyse O Kharbanda","doi":"10.1177/00333549241280002","DOIUrl":null,"url":null,"abstract":"Objectives: The HealthPartners' Vaccine Safety Datalink (VSD) team maintains standardized files of vaccines from medical and pharmacy claims and electronic health records (established data sources) for safety surveillance. Since 2021, for selected vaccines, data from the Minnesota Immunization Information Connection (MIIC), Minnesota's immunization information system, have been added to the HealthPartners' VSD files. We examined how MIIC data have enhanced the identification of novel and routine vaccines.Methods: We describe the approach to incorporating MIIC data. We determined and compared the number and proportion of vaccines identified from established data sources with the additional capture of vaccine data identified from MIIC, in which age group and period of observation varied by vaccine.Results: As of December 31, 2023, of 1 099 411 people in the HealthPartners' VSD cohort, 1 001 400 people (91%) were linked with an MIIC record. Across all data sources, for the full cohort, >2.7 million COVID-19 vaccine doses were recorded since 2020, >4000 mpox vaccine doses since 2022, >7.3 million influenza vaccine doses since 2004, >600 000 human papillomavirus (HPV) vaccine doses since 2006, and >1.1 million diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine doses since 2004. For COVID-19 vaccines, about 30% of vaccine doses were exclusively captured from MIIC, with the remaining 70% from established data sources. For the mpox vaccine, about 42% were exclusively from MIIC. For influenza, HPV, and DTaP vaccines, about 20%, 14%, and 17%, respectively, were exclusively identified from MIIC.Conclusions: Incorporation of data from state immunization information systems into existing vaccine data files can enhance monitoring on the safety of novel vaccines administered outside traditional health care settings and can enhance data quality for routine childhood and adult vaccines.","PeriodicalId":20793,"journal":{"name":"Public Health Reports","volume":" ","pages":"333549241280002"},"PeriodicalIF":3.0000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556530/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00333549241280002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: The HealthPartners' Vaccine Safety Datalink (VSD) team maintains standardized files of vaccines from medical and pharmacy claims and electronic health records (established data sources) for safety surveillance. Since 2021, for selected vaccines, data from the Minnesota Immunization Information Connection (MIIC), Minnesota's immunization information system, have been added to the HealthPartners' VSD files. We examined how MIIC data have enhanced the identification of novel and routine vaccines.

Methods: We describe the approach to incorporating MIIC data. We determined and compared the number and proportion of vaccines identified from established data sources with the additional capture of vaccine data identified from MIIC, in which age group and period of observation varied by vaccine.

Results: As of December 31, 2023, of 1 099 411 people in the HealthPartners' VSD cohort, 1 001 400 people (91%) were linked with an MIIC record. Across all data sources, for the full cohort, >2.7 million COVID-19 vaccine doses were recorded since 2020, >4000 mpox vaccine doses since 2022, >7.3 million influenza vaccine doses since 2004, >600 000 human papillomavirus (HPV) vaccine doses since 2006, and >1.1 million diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine doses since 2004. For COVID-19 vaccines, about 30% of vaccine doses were exclusively captured from MIIC, with the remaining 70% from established data sources. For the mpox vaccine, about 42% were exclusively from MIIC. For influenza, HPV, and DTaP vaccines, about 20%, 14%, and 17%, respectively, were exclusively identified from MIIC.

Conclusions: Incorporation of data from state immunization information systems into existing vaccine data files can enhance monitoring on the safety of novel vaccines administered outside traditional health care settings and can enhance data quality for routine childhood and adult vaccines.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

截至 2023 年 12 月 31 日，通过与明尼苏达州免疫信息连接的链接，提高疫苗安全监测的疫苗识别率。

目标：HealthPartners 的疫苗安全数据链 (VSD) 团队从医疗和药房报销单以及电子健康记录（已建立的数据源）中维护疫苗的标准化档案，以进行安全监测。自 2021 年起，对于部分疫苗，来自明尼苏达州免疫信息系统 Minnesota Immunization Information Connection (MIIC) 的数据被添加到 HealthPartners 的 VSD 文件中。我们研究了 MIIC 数据如何提高了新型疫苗和常规疫苗的识别能力：我们介绍了纳入 MIIC 数据的方法。我们确定并比较了从既有数据源中识别的疫苗数量和比例，以及从 MIIC 中识别的额外获取的疫苗数据，其中年龄组和观察期因疫苗而异：截至 2023 年 12 月 31 日，在 HealthPartners 的 VSD 队列中的 1099 411 人中，有 1001400 人（91%）与 MIIC 记录相关联。在所有数据源中，整个队列自 2020 年以来记录的 COVID-19 疫苗剂量超过 270 万剂，自 2022 年以来记录的 mpox 疫苗剂量超过 4000 剂，自 2004 年以来记录的流感疫苗剂量超过 730 万剂，自 2006 年以来记录的人乳头瘤病毒 (HPV) 疫苗剂量超过 60 万剂，自 2004 年以来记录的白喉、破伤风类毒素和无细胞百日咳 (DTaP) 疫苗剂量超过 110 万剂。就 COVID-19 疫苗而言，约 30% 的疫苗剂量完全来自 MIIC，其余 70% 来自已有的数据源。至于麻风腮疫苗，约 42% 的剂量完全来自 MIIC。至于流感疫苗、人乳头瘤病毒疫苗和百白破疫苗，分别约有 20%、14% 和 17% 完全来自 MIIC：结论：将州免疫信息系统的数据纳入现有的疫苗数据文件可加强对传统医疗机构外接种的新型疫苗安全性的监测，并可提高常规儿童和成人疫苗的数据质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Public Health Reports 医学-公共卫生、环境卫生与职业卫生

CiteScore

5.00

自引率

6.10%

发文量

164

审稿时长

6-12 weeks

期刊介绍： Public Health Reports is the official journal of the Office of the U.S. Surgeon General and the U.S. Public Health Service and has been published since 1878. It is published bimonthly, plus supplement issues, through an official agreement with the Association of Schools and Programs of Public Health. The journal is peer-reviewed and publishes original research and commentaries in the areas of public health practice and methodology, original research, public health law, and public health schools and teaching. Issues contain regular commentaries by the U.S. Surgeon General and executives of the U.S. Department of Health and Human Services and the Office of the Assistant Secretary of Health. The journal focuses upon such topics as tobacco control, teenage violence, occupational disease and injury, immunization, drug policy, lead screening, health disparities, and many other key and emerging public health issues. In addition to the six regular issues, PHR produces supplemental issues approximately 2-5 times per year which focus on specific topics that are of particular interest to our readership. The journal''s contributors are on the front line of public health and they present their work in a readable and accessible format.